All Stories

  1. Population Pharmacokinetics and Target Engagement of Natalizumab in Patients With Multiple Sclerosis

    Article • The Journal of Clinical Pharmacology, April 2017, Wiley

    Bharath Kumar Kandadi Muralidharan